Lataa...
Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
Soluble amyloid-beta oligomers (Aβo) start to accumulate in the human brain one to two decades before any clinical symptoms of Alzheimer's disease (AD) and are implicated in synapse loss, one of the best predictors of memory decline that characterize the illness. Cognitive impairment in AD was...
Tallennettuna:
| Julkaisussa: | Front Mol Neurosci |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7817907/ https://ncbi.nlm.nih.gov/pubmed/33488358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2020.600084 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|